The reading room / Peptide research blog

Peptide research, explained.

Detailed guides to peptide identity, biological pathways, analytical methods and clinical evidence. Search the reading room or follow a research topic.

Browse 13 research topics
Reset filters

All guides & articles

121–132 of 149 guides

Page 11 of 13
Clinical balance-scale evidence photograph with physically separated Treatment and Follow-up folders and a sharp stopping-date divider, in the Weight Regain After Stopping Semaglutide research file.Research Practice

Weight Regain After Stopping Semaglutide: What STEP Studied

The often-quoted claim that people regain two-thirds of their weight loss after stopping semaglutide comes from a particular follow-up study.

Updated 2026-10-29 ↗
Setmelanotide dossier with an MC4 signaling index card, genetics references and a clinical eligibility file.Peptide Fundamentals

Setmelanotide: MC4 Signaling and Specific Obesity Conditions

Setmelanotide is an MC4-receptor agonist with a clinical record tied to specified causes and contexts of obesity.

Updated 2026-10-29 ↗
Skin-layer teaching model with separate copper peptide, signal peptide and product-study research sleeves.Research Practice

Skin-Care Peptides: Copper Complexes, Signal Peptides and Evidence

A skin-care peptide claim is strongest when it points to the tested finished formulation and a defined skin outcome.

Updated 2026-10-29 ↗
short-bowel teaching specimen and an archived support-requirements file, in the Teduglutide and GLP-2 research file.Peptide Fundamentals

Teduglutide and GLP-2: Evidence in Short Bowel Syndrome

Teduglutide is a GLP-2 analogue whose clinical record concerns short bowel syndrome with dependence on parenteral support.

Updated 2026-10-29 ↗
heart-chamber teaching model and a clinical symptom-record folio alongside a weight-scale photo, heading SUMMIT / HFpEF, in the Tirzepatide in HFpEF research file.Research Practice

Tirzepatide in HFpEF: What SUMMIT Adds Beyond Weight Loss

SUMMIT studied tirzepatide in people with obesity and heart failure with preserved ejection fraction.

Updated 2026-10-29 ↗
liver teaching cutaway and steatosis and fibrosis teaching specimen tiles in a histology archive drawer, main heading SYNERGY-NASH, in the Tirzepatide and MASH research file.Research Practice

Tirzepatide and MASH: What SYNERGY-NASH Can Establish

A liver-enzyme improvement, a reduction in liver fat and a change in biopsy-defined MASH describe different findings.

Updated 2026-10-29 ↗
Nighttime photograph of unoccupied sleep-study equipment beside a upper-airway teaching model, in the Tirzepatide and Sleep Apnea research file.Research Practice

Tirzepatide and Sleep Apnea: What SURMOUNT-OSA Measured

Tirzepatide sleep-apnea research is strongest when the breathing measurement stays attached to the result.

Updated 2026-10-29 ↗
Empty capsule specimen holder and a sealed injection-formulation archive tray, each attached to an independent study packet, in the VK2735 research file.Research Practice

VK2735: Reading VENTURE and the Oral Research Separately

VK2735 has been studied as an injected and an oral GIP/GLP-1 receptor agonist, but the two research records should not be fused into one result.

Updated 2026-10-29 ↗
long-bone end teaching specimen and an enlarged cartilage growth-plate model in a pale padded specimen box, in the Vosoritide research file.Peptide Fundamentals

Vosoritide: CNP Signaling, Growth Velocity and Achondroplasia

Vosoritide is a C-type natriuretic peptide analogue studied for achondroplasia. Its evidence concerns growth-plate biology and growth velocity in an eligible pediatric population, not a general height-enhancement claim.

Updated 2026-10-29 ↗
natural cone-snail shell preserved in a conservation box beside a resin neuron teaching specimen, in the Ziconotide research file.Peptide Fundamentals

Ziconotide: A Conopeptide with a Very Specific Clinical Role

Ziconotide is a conopeptide medicine with a highly specific pain-management setting and route. Its N-type calcium-channel binding helps explain the research rationale, but the product record also contains substantial safety restrictions.

Updated 2026-10-29 ↗
Two endocrine research binders GHRH and GHRP, with one shared GH response specimen holder below them, in the GHRH vs GHRP research file.Peptide Fundamentals

GHRH vs GHRP: Understanding Growth Hormone Peptides

GHRH-related peptides and GHRP-related secretagogues can both appear in growth-hormone research, but they are not one interchangeable group.

Updated 2026-10-29 ↗
Four separate research compartments labeled GLP-1, GIP, glucagon and amylin inside a classified reference file.Peptide Fundamentals

GLP-1, GIP, Glucagon and Amylin Peptides Compared

GLP-1, GIP, glucagon and amylin name different signaling systems, not four interchangeable versions of one weight-loss peptide.

Updated 2026-10-29 ↗
Peptide Research Guides & Evidence: Page 11 | PeptideTwo